The topical administration of 7H-dibenzo[c,g]carbazole (7H-DBC) at very low but repeated doses causes genotoxic effects such as DNA adduct formation and produces hepatocellular apoptosis in mouse liver. The purpose of this work was to investigate the alterations in gene expression and protein levels of biomarkers associated with the p53 pathway in mouse liver after exposure to cumulative low doses of 7H-DBC by skin paint applications. The compound was administered topically at the dose of 13.35 μg per animal every 2 days to give either 6, 8, 10, or 12 applications. Animals were sacrificed 48 hours after the different treatments. The apoptotic index increased with the number of applications, with a major proportion of apoptotic cells in the periportal areas. A significant increase of Bax mRNA and protein expression was observed after the 8th application whereas the expression of mRNA levels of Fas and p53 did not show significant differences between treated and control animals. Nuclear staining of p53 was detected in hepatocyte nuclei showing the activation of this protein. Later in the apoptosis process we observed the up-regulation of TGF-β1 in parenchymal cells. In addition to the induction of the p53 apoptosis pathway in vivo by 7H-DBC, we have observed molecular changes related to cell proliferation such as the overexpression of the antiapoptotic gene Bcl-2.
Bartek, J., Bartkova, J., Vojtesek, B., Staskova, Z., Rejthar, A., Kovarik, J., and Lane, D.P. (1990). Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int J Cancer46, 839—44.
2.
Bedossa, P., Peltier, E., Terris, B., Franco, D., and Poynard, T. (1995). Transforming growth factor β1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic and neoplastic human livers . Hepatology21, 760—6.
3.
Binkova, B., Giguere, Y., Rossner, P., Dostal, M., and Sram, R.J. (2000). The effect of dibenzo(a,l)pyrene and benzo(a)pyrene on human diploid lung fibroblasts: the induction of DNA adducts, expression of p53 and p21(WAF1) proteins and cell cycle distribution. Mutat Res971, 57—70.
4.
Bjerlogrlic, N., Mäkinen, M., Stenbäck, F., and Vähäkanga, K. (1994). Benzo(a)pyrene-7,8-diol-9,10-epoxide-DNA adducts and increased p53 protein in mouse skin. Carcinogenesis15, 771—4.
5.
Braun, L., Gruppuso, P., Mikumo, R., and Fausto, N. (1990). Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects. Cell Growth Differ1, 103—11.
6.
Braun, L., Mead, J.E., Panzica, M., Mikumo, R., Bell, G.I., and Fausto, N. (1988). Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation . Proc Natl Acad Sci USA85, 1539—43.
7.
Carlisle, D.L., Pritchard, D.E., Singh, J., Owens, B.M., Blanknship, L.J., Orenstein, J.M., and Patiermo, S.R. (2000). Apoptosis and p53 induction in human lung fibroblasts exposed to chromium (VI): effect of ascorbate and tocopherol. Toxicol Sci55, 60—8.
8.
Charlotte, F., Hermine, A.L., Martin, N., Geleyn, Y., Nollet, M., Gaulard, P., and Zafrani, E.S. (1994). Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Amer J Pathol144, 460—5.
9.
Czaja, M.J., Weiner, F.R., Flanders, K.C., Giambrone, R., Wind, L., Biempica, L., and Zern, M.A. (1989). In vitro and in vivo association of transforming growth factor β1 with hepatic fibrosis. J Cell Biol108, 2477—82.
10.
Denissenko, M.F., Koudriakova, T.B., Smith, L., O'Connor, T.R., Riggs, A.D., and Pfeifer, G.P. (1998). The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts. Oncogene17, 3007—14.
11.
Dorchies, O., Perin-Roussel, O., Gillardeaux, O., Vericat, J.A., Roome, N.O., Prenez, A., and Perin, F. (2001). Induction of DNA synthesis in mouse liver following increases of DNA adduct levels elicited by very low cumulative doses of the genotoxic hepatocarcinogen 7H-dibenzo(c,g)carbazole. Toxicol Pathol29, 528—34.
12.
Fausto, N., Mead, J.E., Gruppuso, P.A., and Braun, L. (1990). TGF-β in liver development regeneration and carcinogenesis. Ann NY Acad Sci593, 231— 42.
13.
Fritsche, M., Haessler, C., and Brandner, G. (1993). Induction of nuclear accumulation of the tumour-suppressor protein p53 by DNA-damaging agents. Oncogene8, 307—18.
14.
Gilliland, G., Perrin, S., Blanchard, K., and Bunn, H.F. (1990). Analysis of cytokine mRNA and DNA: detection and quantification by competitive polymerase chain reaction. Proc Natl Acad Sci USA87, 2725—9.
15.
Gottlieb, T.M., and Oren, M. (1996). p53 in growth control and neoplasia. Biochem Biophys Acta1287, 77—102.
16.
Harnois, D.M., Que, F.G., Celli, A., LaRusso, N.F., and Gores, G.J. (1997). Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line. Hepatology26, 884—90.
17.
Kastan, M.B., Onyekwere, O., Sindransky, D., Vogelstein, B., and Craig, R.W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res51, 6304—11.
18.
Kobertz, W.R., Wang, D., Wogan, G.N., and Essigmann, J.M. (1997). An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspot. Proc Natl Acad Sci USA94, 9579—84.
19.
Lane, D.P. (1992). p53, guardian of the genome. Nature358, 15—6.
20.
Levine, A.J. (1997). p53, the cellular gatekeeper for growth and division . Cell88, 323—31.
21.
Lim, I.K. (2002). Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fisher 344 male rats. Mech Ageing Dev123, 1665—80.
22.
Liu, M., Dhanwada, K.R., Birt, D.F., Hecht, S., and Pelling, X. (1994). Increase in p53 protein half-life in mouse keratinocytes following UV-B irradiation. Carcinogenesis15, 1089—92.
23.
Mace, K., Aguilar, F., Wang, J.S., Vautravers, P., Gomez-Lechon, M., Gonzalez, F.J., Groopman, J., Harris, C.C., and Pfeifer, A.M. (1997). Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis18, 1291—7.
24.
Mitry, R.R., Sarraf, C.E., Chuang-Ging, W., Pignatelli, M., and Habib, N.A. (1997). Wild-type p53 induces apoptosis in Hep3B trough up-regulation of Bax expression. Lab Invest77, 369—78.
25.
Miyashita, T., Krajewski, S., Krajeweski, M., Wang, H.G., Lin, H.K., Liebermann, D.A., Hoffman, B., and Reed, J.C. (1994). Tumour suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene9, 1799—805.
26.
Moll, U.M., Ostermeyer, A.G., Haladay, R., Winkfield, B., Frazier, M., and Zambetti, G. (1996). Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol Cell Biol16, 1126— 37.
27.
Muller, M., Strand, S., Hug, H., Heinemann, E.M., Walzack, H., Hofmann, W.J., Stremmel, W., Krammer, P.H., and Galle, P.R. (1997). Drug induced apoptosis in hepatoma cells is mediated by the CD95(APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest99, 403—13.
28.
Oberhammer, F.A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio. A.F., Bursch, W., and Schulte-Hermann, R. (1992). Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1 (mature and latent transforming growth factor β1). Proc Natl Acad Sci USA89, 5408—12.
29.
O'Brien, T., Babcock, G., Cornelius, J., Dingeldein, M., Talaska, G., Warshawsky, D., and Mitchell, K. (2000). A comparison of apoptosis and necrosis induced by hepatotoxins in HepG2 cells. Toxicol Appl Pharmacol164, 280—90.
30.
Owen-Schaub, L.B., Zhang, W., Cusack, J.C., Angelo, L.S., Santee, S.M., Fujiwara, T., Roth, J.A., Deisseroth, A.B., Zhang, W.W., Kruzel, E., and Radinsky, R. (1995). Wild type human p53 and temperature-sensitive mutant induce Fas/APOI expression. Mol Cell Biol15, 3032— 40.
31.
Patel, T., and Gores, G.J. (1995). Apoptosis and hepatobiliary disease. Hepatology21, 1725—41.
32.
Périn-Roussel, O., Périn, F., Barat, N., Plessis, M.J., and Zajdela, F. (1995). Interaction of 7H-dibenzo[c,g]carbazole and its organospecific derivates with hepatic mitochondrial and nuclear DNA in the mouse. Environ Mol Mutagen25, 202—10.
33.
Périn, F., Valéro, D., Mispelter, J., and Zajdela, F. (1984). In vitro metabolism of N-methyl-dibenzo(c,g)carbazole, a potent sarcomatogen devoid of hepatotoxic and hepatocarcinogenic properties . Chem Biol Interact48, 281— 95.
34.
Périn, F., Valéro, D., Thybaud-Lambay, V., Plessis, M.J., and Zajdela, F. (1988). Organ specific, carcinogenic dibenzo[c,g]carbazole derivatives: discriminative response in S.Typhimurium TA100 mutagenesis modulated by subcellular fractions of mose liver. Mutat Res198, 15—26.
35.
Rämet, M., Castrén, K., Järvinen, K., Pekkala, K., Turpeenniemi-Hujanen, T., Soini, Y., Pääkkö, P., and Vähäkangas, K. (1995). p53 protein expression is correlated with benzo(a)pyrene-DNA adducts in carcinoma cell lines. Carcinogenesis16, 2117—24.
36.
Roberts, A.B., Thompson, N.L., Heine, U., Flanders, C., and Sporn, M.B. (1988). Transforming growth factor-β: possible roles in carcinogenesis. Br J Cancer57, 594—600.
37.
Russell, W.E., Coffey, R.J., Jr., Ouellette, A.J., and Moses, H.L. (1988). Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat . Proc Natl Acad Sci USA85, 5126—30.
38.
Ryan, J.J., Prochownick, E., Gottlieb, C.A., Apel, I.J., Merino, R., Nuñez, G., and Clarke, M.F. (1994). c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA91, 5878—82.
39.
Selvey, S., Thompson, E.W., Matthaei, K., Lea, R.A., Irving, M.G., and Griffiths, L.R. (2001) β-Actin an unsuitable internal control for RT-PCR. Mol Cell Probes15, 307—11.
40.
Shaulsky, G., Goldfinger, N., Peled, A., and Rotter, V. (1991). Involvement of wild-type p53 protein in the cell cycle requires nuclear localization. Cell Growth Differ2, 661—7.
41.
Sporn, M.B., and Roberts, A.B. (1985). Autocrine growth factors and cancer. Nature313, 745—7.
42.
Stommel, J.M., Marchenko, N.D., Jimenez, G.S., Moll, U.M., Hope, T.J., and Whal, G.M. (1999). A leucine-rich nuclear export signal in the p53 tetrameization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J18, 1660—72.
43.
Tombolan, F., Renault, D., Brault, D., Guffroy, M., Périn-Roussel, O., Périn, F., and Thybaud, V. (1999a). Kinetics of induction of DNA adducts, cell proliferation and gene mutations in the liver of MutaTM mice treated with 5,9-dimethyl-dibenzo[c,g]carbazole . Carcinogenesis20, 125—32.
44.
Tombolan, F., Renault, D., Brault, D., Guffroy, M., Périn, F., and Thybaud, V. (1999b). Effect of mitogenic or regenerative cell proliferation on lacZ mutant frequency in the liver of MutaTMMice treated with5,9-dimethyldibenzo[c,g]carbazole . Carcinogenesis20, 1357—999.
45.
Valéro, D., Perin, F., Plessis, M.J., and Zajdela, F. (1985). Sexual differences in the expression of gamma-glutamyl transpeptidase during 5,9-dimethyldibenzo[c,g]carbazole induced hepatocarcinogenesis in mouse. Cancer Lett27, 181—7.
46.
van Gijssel, H.E., Maassen, C.B.M., Mulder, G.J., and Meerman, J.H.N. (1997). p53 protein expression by hepatocarcinogens in the rat liver and its potential role in mitoinhibition of normal hepatocytes as a mechanism of hepatic tumour progression. Carcinogenesis18, 1027—33.
47.
Vogelstein, B., and Kinzler, K.W. (1992). p53 function and dysfunction. Cell70, 523—6.
48.
Wang, A.M., Doyle, M.V., and Mark, D.F. (1989). Quantification of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA86, 9717—21.
49.
Washawsky, D., Talaska, G., Jue, W., and Schneider, J. (1996). Comparative carcinogenicity, metabolism, mutagenicity and DNA binding of 7H-dibenzo(c,g)carbazole and dibenzo(a,j)acridine. Crit Rev Toxicol26, 213— 49.
50.
Wolter, K.G., Hsu, Y.T., Smith, C.L., Nechushtan, A., Xi, X.G., and Youle, R.J. (1997). Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol139, 1281—92.
51.
Yin, C., Knudson, C.M., Korsmeyer, S.J., and van Dyke, T. (1997). Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature385, 637— 40.
52.
Yoshizawa, K., Nambu, H., Yang, J., Oishi, Y., Senzaki, H., Shikata, N., Miki, H., and Tsubura, A. (1999). Mechanisms of photoreceptor cell apoptosis induced by N-methyl-N-nitrosurea in Sprague—Dawley rats. Lab Invest79, 1359—67.
53.
Zhang, X., Wang, T., Batist, G., and Tsao, M.S. (1994). Transforming growth factor β1 promotes spontaneous transformation of cultured rat liver epithelial cells. Cancer Res54, 6122—8.
